Neurowyzr offers the Digital Brain Function Screen (DBFS), an online, gamified neuroscience assessment that measures immediate memory, working memory, attention and executive function in about 15–20 minutes. DBFS is hosted via web browser for at-home access but was designed for primary care settings and uses puzzles to reduce tester bias versus traditional pen-and-paper tests. The tool is registered with the U.S. FDA, Singapore Health Sciences Authority and Australia Therapeutic Goods Administration, and is in use at healthcare organizations including Parkway Shenton, SATA Commhealth, Farrer Park Hospital, MHC Medical Centre (Amara) and O’Joy; it has also completed a pilot with a large private hospital chain in India. Neurowyzr was founded in 2019 and has offices in Singapore and India. The company is working with academic partners such as NTU Lee Kong Chian School of Medicine’s Dementia Research Centre to develop additional digital brain-health solutions. It plans to use new funding for product development and regional expansion across Southeast Asia and India.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2023